These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31978591)

  • 21. Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy.
    Hatiboglu G; Pinkawa M; Vallée JP; Hadaschik B; Hohenfellner M
    BJU Int; 2012 Dec; 110(11 Pt B):E647-52. PubMed ID: 22788857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrogel Spacer Reduces Rectal Dose during Proton Therapy for Prostate Cancer: A Dosimetric Analysis.
    Polamraju P; Bagley AF; Williamson T; Zhu XR; Frank SJ
    Int J Part Ther; 2019; 5(4):23-31. PubMed ID: 31773038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results.
    Mahal BA; Ziehr DR; Hyatt AS; Neubauer-Sugar EH; O'Farrell DA; O'Leary MP; Steele GS; Niedermayr TR; Beard CJ; Martin NE; Orio PF; D'Amico AV; Devlin PM; Nguyen PL
    Brachytherapy; 2014; 13(5):442-9. PubMed ID: 24880584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
    Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
    Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer.
    Folkert MR; Zelefsky MJ; Hannan R; Desai NB; Lotan Y; Laine AM; Kim DWN; Neufeld SH; Hornberger B; Kollmeier MA; McBride S; Ahn C; Roehrborn C; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):101-109. PubMed ID: 33753140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
    Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
    Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a hydrogel spacer in three-dimensional conformal radiation therapy for prostate cancer.
    Ogita M; Yamashita H; Sawayanagi S; Takahashi W; Nakagawa K
    Jpn J Clin Oncol; 2020 Mar; 50(3):303-309. PubMed ID: 31926489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of a rectal hydrogel spacer on dosimetric and toxicity outcomes among patients undergoing combination therapy with external beam radiotherapy and low-dose-rate brachytherapy.
    Nehlsen AD; Sindhu KK; Moshier E; Sfakianos JP; Stock RG
    Brachytherapy; 2021; 20(2):296-301. PubMed ID: 33199175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the Quality-of-Life Effect of Apical Spacing with Hyaluronic Acid Prior to Hypofractionated Prostate Radiation Therapy: A Secondary Analysis.
    King MT; Svatos M; Chell EW; Pigrish V; Miller K; Low DA; Orio PF
    Pract Radiat Oncol; 2024; 14(3):e214-e219. PubMed ID: 38043644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
    Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
    Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapy.
    Qi XS; Wang JP; Gomez CL; Shao W; Xu X; King C; Low DA; Steinberg M; Kupelian P
    Radiother Oncol; 2016 Oct; 121(1):113-117. PubMed ID: 27587270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy.
    Yeh J; Lehrich B; Tran C; Mesa A; Baghdassarian R; Yoshida J; Torrey R; Gazzaniga M; Weinberg A; Chalfin S; Ravera J; Tokita K
    Brachytherapy; 2016; 15(3):283-287. PubMed ID: 26853354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
    Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.
    Huang EH; Pollack A; Levy L; Starkschall G; Dong L; Rosen I; Kuban DA
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1314-21. PubMed ID: 12459352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial.
    Nguyen PL; Chen RC; Hoffman KE; Trofimov A; Efstathiou JA; Coen JJ; Shipley WU; Zietman AL; Talcott JA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1081-5. PubMed ID: 20207497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy.
    Beydoun N; Bucci JA; Chin YS; Malouf D; Enari E; Painter SD
    Brachytherapy; 2013; 12(4):368-74. PubMed ID: 23453682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric uncertainty in prostate cancer proton radiotherapy.
    Lin L; Vargas C; Hsi W; Indelicato D; Slopsema R; Li Z; Yeung D; Horne D; Palta J
    Med Phys; 2008 Nov; 35(11):4800-7. PubMed ID: 19070212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life.
    Seymour ZA; Pinkawa M; Daignault-Newton S; Bosch W; Michalski JM; Gay H; Hamstra DA
    Front Oncol; 2023; 13():1239104. PubMed ID: 37886176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.